Search - tctmd.com

Displaying 561 - 580 of 876

Sort: Relevancy | Date

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

News Daily News

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Shelley Wood

April 13, 2018

News Daily News

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Michael O'Riordan

April 05, 2018

News Daily News

Unplanned Readmissions Within 30 Days Post-PCI Affect Nearly One in 10 US Patients

L.A. McKeown

April 04, 2018

News Daily News

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

Yael L. Maxwell

March 30, 2018

News Daily News

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Shelley Wood

March 29, 2018

News Conference News ACC 2018

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Caitlin E. Cox

March 19, 2018

News Conference News ACC 2018

Low-Dose, Three-Drug Polypill TRIUMPHs for Blood Pressure

Shelley Wood

March 12, 2018

News Conference News ACC 2018

Mixing Haircuts and Hypertension Rx a ‘Home Run’ for Blood Pressure Control

Todd Neale

March 12, 2018

News Conference News ACC 2018

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

Michael O'Riordan

March 12, 2018

News Daily News

Less Aggressive HbA1c Targets Recommended by American College of Physicians

Michael O'Riordan

March 06, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Daily News

Multivessel PCI Improves Outcomes in STEMI Patients With Cardiogenic Shock: Korean Registry

Caitlin E. Cox

February 23, 2018

News Daily News

ICD Benefit Questioned in Patients With Chronic Kidney Disease

Todd Neale

February 09, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

One-Third of TAVR and SAVR Patients Are Depressed, Upping Mortality Risk

L.A. McKeown

January 18, 2018

STEMI Patients With Multivessel Disease Best Served by a Single Procedure: Meta-analysis

News Daily News

STEMI Patients With Multivessel Disease Best Served by a Single, Complete Procedure: Meta-analysis

Caitlin E. Cox

December 15, 2017

News Daily News

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Caitlin E. Cox

December 13, 2017

News Daily News

Some Concerns About New ‘Tour de Force’ Hypertension Guidelines

Todd Neale

December 04, 2017

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Caitlin E. Cox

November 30, 2017

Advertisement

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Unplanned Readmissions Within 30 Days Post-PCI Affect Nearly One in 10 US Patients

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

Time for Guidelines to Recommend ARBs Over ACE Inhibitors?

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Low-Dose, Three-Drug Polypill TRIUMPHs for Blood Pressure

Mixing Haircuts and Hypertension Rx a ‘Home Run’ for Blood Pressure Control

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

Less Aggressive HbA1c Targets Recommended by American College of Physicians

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Multivessel PCI Improves Outcomes in STEMI Patients With Cardiogenic Shock: Korean Registry

ICD Benefit Questioned in Patients With Chronic Kidney Disease

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

One-Third of TAVR and SAVR Patients Are Depressed, Upping Mortality Risk

STEMI Patients With Multivessel Disease Best Served by a Single, Complete Procedure: Meta-analysis

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Some Concerns About New ‘Tour de Force’ Hypertension Guidelines

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content